Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins ; volume:5 ; number:1 ; day:26 ; month:9 ; year:2006 ; pages:1-8 ; date:12.2006
Cardiovascular diabetology ; 5, Heft 1 (26.9.2006), 1-8, 12.2006
- Creator
-
Tenenbaum, Alexander
Fisman, Enrique Z.
Motro, Michael
Adler, Yehuda
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1475-2840-5-20
- URN
-
urn:nbn:de:101:1-2021082521110282824475
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tenenbaum, Alexander
- Fisman, Enrique Z.
- Motro, Michael
- Adler, Yehuda
- SpringerLink (Online service)
Other Objects (12)
Safety of Prescribing Statins in Childhood Dyslipidemia
Search for genetic factors predisposing to atherogenic dyslipidemia
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
The role of dyslipidemia and statins in venous thromboembolism
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Hypertension and Dyslipidemia Combined Therapeutic Approaches
Inpatient therapeutic options
Future therapeutic options
Targeting AMPK by Statins: A Potential Therapeutic Approach
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Safety of Prescribing Statins in Childhood Dyslipidemia
Search for genetic factors predisposing to atherogenic dyslipidemia
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
The role of dyslipidemia and statins in venous thromboembolism
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Hypertension and Dyslipidemia Combined Therapeutic Approaches
Inpatient therapeutic options
Future therapeutic options
Targeting AMPK by Statins: A Potential Therapeutic Approach
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Safety of Prescribing Statins in Childhood Dyslipidemia
Search for genetic factors predisposing to atherogenic dyslipidemia
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
The role of dyslipidemia and statins in venous thromboembolism
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Hypertension and Dyslipidemia Combined Therapeutic Approaches
Inpatient therapeutic options
Future therapeutic options
Targeting AMPK by Statins: A Potential Therapeutic Approach
Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation